1-4 of 4
Gerwin A. Huls, MD, PhD
Close
Sort by
Journal Articles

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart, MD, Chloé Reiniers, Tim Bagguley, Corine van Marrewijk, PhD, David Bowen, MD PhD, Jaroslav Cermak, MD PhD As. Prof., Eva Hellström-Lindberg, MD PhD, Aurelia Tatic, MD, Argiris Symeonidis, MD PhD, Gerwin A Huls, MD PhD, Alex Smith, Theo de Witte, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3267.
https://doi.org/10.1182/blood.V124.21.3267.3267
Published: 2014
Journal Articles

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Jurjen Versluis, MD, Raynier Devillier, MD, Florentien in 't Hout, MD, Wim van Putten, MSc, Markus G Manz, MD, Marie-Christianne Vekemans, MD, Martyn Ronald Schaafsma, MDPhD, Jakob R Passweg, MD, Johan Maertens, MD PhD, Jurgen H Kuball, MDPhD, Leo F. Verdonck, MD PhD, Bart J Biemond, MD, Peter J.M. Valk, PhD, Marie-Joelle Mozziconacci, MD PhD, Norbert Vey, MD PhD, Harry C Schouten, MDPhD, Edo Vellenga, MDPhD, Thomas Pabst, MD, Bob Lowenberg, MDPhD, Gert J Ossenkoppele, MD PhD, Didier Blaise, MD PhD, Gerwin A Huls, MD PhD, Jan J Cornelissen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 323.
https://doi.org/10.1182/blood.V124.21.323.323
Published: 2014
Journal Articles

Patterns of Primary Treatment, Trial Participation and Survival in Adult Acute Myeloid Leukemia: A Nationwide Population-Based Study Among Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Otto Visser, MD PhD, Yvette van Norden, MSc, PhD, Nicole MA Blijlevens, MD PhD, Jan J. Cornelissen, MD PhD, Gerwin A Huls, MD PhD, Peter C Huijgens, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Gert J Ossenkoppele, MD PhD, Bob Löwenberg, MD PhD, Mojca Jongen-Lavrencic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2631.
https://doi.org/10.1182/blood.V124.21.2631.2631
Published: 2014
Journal Articles

In Vivo Treatment of AML Patients with High-Dose Simvastatin Inhibits Geranylgeranylation In AML Cells

Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Gerwin A. Huls, MD, PhD, Rudolf S.N. Fehrmann, Jan J. Schuringa, PhD, Folkert Kuipers, PhD, Elisabeth G.E. de Vries, MD, PhD, Edo Vellenga, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3280.
https://doi.org/10.1182/blood.V116.21.3280.3280
Published: 2010